Interdisciplinary Symposium on Osteoporosis 2026 (ISO2026)

Highlights from Margie Bissinger

Time Line:

  • [00:00] - FDA approves total hip BMD as endpoint for drug trials
  • [01:57] - Oral Forteo: first pill version of anabolic drug
  • [04:29] - Removal of estrogen black box warning and implications
  • [10:16] - Estrogen for bone health, heart, and colon protection
  • [11:36] - Short-course anabolic therapy vs. maintenance therapy
  • [16:35] - Importance of medication sequencing
  • [24:30] - Bone turnover markers for monitoring progress
  • [32:04] - New screening guidelines for women
  • [37:55] - Bone medication and cardiovascular risk
  • [40:07] - The use of AI in diagnostics
  • [43:18] - Interdisciplinary care and referrals to physical therapy

Bone Buddies